A new Medicare option for weight loss drugs is coming: Here's what to know

Weight management medications, including Wegovy, Zepbound and Foundayo, will be available to eligible Medicare beneficiaries with a $50 copay starting July. Universal Images Group/Getty Images hide caption toggle caption Universal Images Group/Getty Images Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It’s a…

Read More

'Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds

Surging demand for weight loss and diabetes drugs leaves the pharmaceutical sector at risk from a “bubble effect” as profitability soars, new research suggests. Demand for the likes of Wegovy and Zepbound has driven research and development returns to their highest level in years, but a report published by Deloitte on Monday suggests this is…

Read More